Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06854445
What this trial is testing

Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell B-lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 55
Large-scale testing (Phase 3)Ended earlyNCT00418145
What this trial is testing

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

Who this might be right for
Multiple Sclerosis
Fred Lublin 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06330077
What this trial is testing

Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting Relapsing Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 60
Large-scale testing (Phase 3)Study completedNCT01917019
What this trial is testing

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more
Biogen 101
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05155839
What this trial is testing

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
Shanghai Miracogen Inc. 108
Early research (Phase 1)UnknownNCT05731219
What this trial is testing

UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00262860
What this trial is testing

Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Rochester 18
Not applicableUnknownNCT00810680
What this trial is testing

Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
All India Institute of Medical Sciences 10
Testing effectiveness (Phase 2)Study completedNCT03160079
What this trial is testing

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
University of California, San Diego 16
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Early research (Phase 1)Looking for participantsNCT07121946
What this trial is testing

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedDLBCL - Diffuse Large B Cell LymphomaMantle Cell Lymphoma (MCL)+2 more
LTZ Therapeutics, Inc. 42
Not applicableUnknownNCT04587388
What this trial is testing

Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry

Who this might be right for
Follicular LymphomaRelapsed/Refractory Follicular Lymphoma
European Hematology Association - Lymphoma Group 500
Testing effectiveness (Phase 2)Ended earlyNCT00017069
What this trial is testing

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
CTI BioPharma
Testing effectiveness (Phase 2)Study completedNCT00812669
What this trial is testing

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Who this might be right for
Leukemia
Cancer Trials Ireland 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04536805
What this trial is testing

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

Who this might be right for
Prostate Cancer
Institut Cancerologie de l'Ouest 44
Not applicableStudy completedNCT00859482
What this trial is testing

Differential Immune Effects of Natalizumab

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Cantonal Hospital of St. Gallen 27
Early research (Phase 1)Looking for participantsNCT05366179
What this trial is testing

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Who this might be right for
Glioblastoma Multiforme
UNC Lineberger Comprehensive Cancer Center 36
Early research (Phase 1)Study completedNCT02561962
What this trial is testing

Study in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 42
Testing effectiveness (Phase 2)Ended earlyNCT01636388
What this trial is testing

Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

Who this might be right for
Hodgkins Lymphoma
New York Medical College 2
Next Page